Dan M Roden MD

PubMed

• Unbiased Characterization of Atrial Fibrillation Phenotypic Architecture Provides Insight Into Genetic Liability and Clinically Relevant Outcomes.
  Giovanni Davogustto, Shilin Zhao, Yajing Li, Eric Farber-Eger, Brandon D Lowery
  Circulation. Genomic and Precision Medicine. 2026-01-28
• Genetic evaluation of early-onset atrial fibrillation: impact on patient management.
  J Lukas Laws, Mahsima Shabani, Hollie L Williams, Dakota D Grauherr, Wendy M Kilbourne
  European Heart Journal. 2025-10-30
• 2 citations
  Creating an atlas of variant effects to resolve variants of uncertain significance and guide cardiovascular medicine.
  Andrew M Glazer, Daniel R Tabet, Victoria N Parikh, Brett M Kroncke, Atina G Cote
  Nature Reviews. Cardiology. 2025-09-01

Journal Articles

• A Case Study Evaluating the Portability of an Executable Computable Phenotype Algorithm Across Multiple Institutions and Electronic Health Record Environments  
  Dan M Roden, Joshua C Denny, Huan Mo, Andy Yizhou Wu, Journal of the American Medical Informatics Association
• The Future of Cardiovascular Therapeutics  
  MacRae CA, Roden DM, Loscalzo J, Circulation, 1/1/2016
• Variants in the SCN5A promoter associated with various arrhythmia phenotypes  
  Yagihara N, Watanabe H, Barnett P, Duboscq-Bidot L, Atack TC, Yang P, Ohno S, Hasegawa K, Kuwano R, Chatel S, Redon R, Schott JJ, Probst V, Koopmann TT, Bezzina CR, Wi..., Heart Rhythm, 1/1/2012

Books/Book Chapters

• Cardiac Potassium Channel Disorders: From Basic to Clinics 
  Chapter: Pharmacogenetics of potassium channel blockers. 
  Roden DMEditors: Shenasa M, Nattel S.Elsevier2016
• Practical Electrophysiology the Drug-Induced Long 
  Chapter: Lidocaine Use in a Patient with Old Myocardial Infarction 
  Page 458 - 460Roden DMEditors: Sra J, Akhtar M, Natale A, Wilbert D.Cardiotext Publishing LLC, Minnneapolis, MN2015
• Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine 
  Chapter: Drug Therapeutics and Personalized Medicine 
  Page 75 - 83Roden DMEditors: Bonow R, Mann D, Zipes D, Libby P.Elsevier, Philadelphia, PAEdition 10th,2014

Abstracts/Posters

• Genomic editing in iPSCs establishes that a rare TBX5 variant causes Brugada syndrome.
  Bersell K, Yang T, Hong CC, Petropolulou E, Jamshidi Y, Wells QS, Kannankeril PJ, Roden DM, Student Platform Presentation, ASCI-AAP Annual Meeting, 1/1/2016
• Genomic editing in IPSCs establishes that a rare TBX5 variant casues Brugada syndrome.
  Bersell K, Yang T, Hong CC, Petropolulou E, Jamshidi Y, Wells QS, Kannankeril PJ, Roden DM, Heart Rhytm, 1/1/2016
• Extended GWAS In Brugada Syndrome Uncovers Additional Risk Alleles At The SCN5A/SCN10A Locus With Marked Cumulative Effects On Risk For The Disorder.
  Barc J, Mizusawa Y, Dina C, Gourraud JB, Simonet F, Behr ER, Schulze-Bahr E, Nuyens D, Saenen J, Lambiase PD, Guicheney P, Borggrefe MM, Antzelevitch C, Kaab S, Tfelt-..., Heart Rhytm, 1/1/2016

Lectures

• Considerations for Drug Interactions on QTc Interval in Exploratory COVID-19 Treatment 
  American Heart Association, Scientific Sessions 2010, Chicago, Illinois, USA
• International Conference on Intelligent Biology and Medicine (ICIBM 2013) 
  Vanderbilt University Medical Center(VUMC), Nashville, Tennessee - 8/11/2013

Other

• Implementing Genomic Medicine Globally: We Are Not Alone. 
  Manolio TA, Abramowicz M, Al-Mulla F, Anderson W, Balling R, Berger AC, Chakravarti A, Chantratita W, Chisholm RL, Dissanayake VHW, Dzau VJ, Frebourg T, Han BG, Hubbar..., Science Translational Medicine
  1/3/2015
• Issues expanding in the field of pacing arrhythmia. 
  Roden DM, Today in Cardiology
  1/1/2004
• Atrial Fibrillation. 
  Roden DM, EBM Solutions Guidelines for Health Care Providers and Consumers (online database), Issue 1
  Nashville TN - 1/1/2000